MOLECULAR MEDICINE RESEARCH INSTITUTE (EIN 943254623) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1995

Legal Domicile

Principal Officer

EDWARD P AMENTO MD

Phone

4085236262

Tax Period

2023-01-01 to 2023-12-31

MOLECULAR MEDICINE RESEARCH INSTITUTE, founded in 1995, is a community nonprofit in the Science & Technology sector that reported $1.6M in total revenue in fiscal year 2023. Revenue fell 44% from the prior year — a significant decline worth monitoring. Expenses of $2.9M exceeded revenue, resulting in a 84% operating deficit.

Mission

SCIENTIFIC & MEDICAL RESEARCH

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $194,855

Program Service Revenue $1,374,194

Investment Income $2,050

Other Revenue $0

TOTAL REVENUE $1,571,099

Expense Breakdown

Grants Paid $0

Salaries & Benefits $770,523

Fundraising Expenses $0

Program Expenses $814,881

Other Expenses $2,118,467

TOTAL EXPENSES $2,888,990

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,571,099	$2,786,838	-0.4%
Expenses	$2,888,990	$2,787,511	+0.0%
Net Income	$-1,317,891	$-673	+1957.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$107,708

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
EUGENE BAUER MD	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL A HINDERY	DIRECTOR	1.00	Director	$0	$0	$0
JOHN P ALDERETE PHD MBA	DIRECTOR	1.00	Director	$0	$0	$0
PAUL D MAROTTA JD	BOARD SECRETATY	1.00	Director	$0	$0	$0
EDWARD P AMENTO MD	CEO&TREASURER	40.00	Officer	$107,708	$0	$107,708

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$1,571,099	$2,888,990	$3,036,800	$-1,317,891
2022	$2,786,838	$2,787,511	$3,179,319	$-673
2021	$2,796,900	$3,040,056	$3,545,178	$-243,156
2020	$2,911,904	$3,287,834	$3,283,726	$-375,930
2019	$3,529,155	$3,450,444	$3,361,746	$78,711
2018	$5,889,157	$3,592,097	$3,485,045	$2,297,060

MOLECULAR MEDICINE RESEARCH INSTITUTE